...
首页> 外文期刊>The Annals of Thoracic Surgery: Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association >Incremental Value of Anemia in Cardiac Surgical Risk Prediction With the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II Model
【24h】

Incremental Value of Anemia in Cardiac Surgical Risk Prediction With the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II Model

机译:使用欧洲心脏手术风险评估系统(EuroSCORE)II模型,贫血在心脏外科手术风险预测中的增量价值

获取原文
           

摘要

Study PopulationStatistical AnalysisResultsOutcomeEuroSCORE II MatchingIncremental Value of Anemia Over the EuroSCORE IIAnemia is a risk factor for adverse events after cardiac operations. We evaluated the incremental value of preoperative anemia over the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II to predict hospital death after cardiac operations.MethodsData for 4,594 consecutive adults (1,548 women [33.7%]), aged 67 ± 11 years, who underwent cardiac operations from January 2011 to July 2013 were extracted from the Regional Cardiac Surgery Registry of Puglia. The?last preoperative hemoglobin value was used, according to World Health Organization criteria, to classify anemia as mild (hemoglobin 11.0 to 12.9 g/dL in men and 11.0 to 11.9 g/dL in women) in 1,021 patients (22.2%) and as moderate to severe (hemoglobin <11.0 g/dL) in 593 patients (12.9%). The EuroSCORE II was used to evaluate predicted hospital death after operations. Logistic regression analysis for in-hospital death was performed including EuroSCORE II risk factors and anemia, with model discrimination quantified by C statistic and risk classification by the?use of net reclassification improvement (NRI).ResultsOverall expected and observed mortality rates?were 4.4% and 5.9%. Anemia was significantly associated with a mortality rate of 3.4% in patients without anemia, 7.7% in mild anemia, and 15.7% in moderate to severe anemia (p < 0.001) and also at multivariate analysis correcting for EuroSCORE II (p?
机译:研究人群统计分析结果结果EuroSCORE II匹配的贫血增量值高于EuroSCORE II贫血是心脏手术后发生不良事件的危险因素。我们通过欧洲心脏手术风险评估系统(EuroSCORE)II评估了术前贫血的增量价值,以预测心脏手术后的医院死亡。方法数据连续4,594名成人(1,548名女性,[33.7 %]),年龄67±11岁于2011年1月至2013年7月接受心脏手术的患者,摘自普利亚地区心脏外科手术登记处。根据世界卫生组织的标准,最后的术前血红蛋白值用于将1,021例患者中的轻度贫血分类为轻度贫血(男性为11.0至12.9 g / dL,女性为11.0至11.9 g / dL)(22.2%)在593例患者中为中度至重度(血红蛋白<11.0 g / dL)(12.9%)。 EuroSCORE II用于评估手术后的预计死亡人数。进行了包括EuroSCORE II危险因素和贫血在内的院内死亡的Logistic回归分析,并通过C统计量和风险分类(使用净重分类改进(NRI))对模型歧视进行了量化。结果总体预期和观察到的死亡率为4.4。 %和5.9 %。贫血与无贫血患者的死亡率为3.4%,轻度贫血的死亡率为7.7%,中重度贫血的死亡率为15.7%(p <0.001)以及在对EuroSCORE II进行校正的多变量分析中(p≤0.001)。当使用EuroSCORE II分析贫血时,该模型在区分度(C统计量= 0.852 vs 0.860; p?= 0.007)和重新分类(游离NRI类别,0.592; p <0.001)方面有所改善,从而使校正值与预测值之间保持了良好的一致性。结论术前贫血与心脏外科手术患者的手术死亡密切相关。贫血提供了比EuroSCORE II更高的增值价值,应考虑用于评估心脏手术风险。CTSNet分类:18、23手术风险分层在心脏手术中起着重要作用。多年来,已经提出了各种模型作为术后死亡和发病的预测指标[

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号